health canada approval zepbound tirzepatide obesity canada date approves ZEPBOUND® as the first-ever obstructive sleep apnea medication in for adults living with Canadians on Tirzepatide for Weight

Oxidative stress and SASP are revealed as deeply interconnected processes, emphasizing the need for dual-targeting approaches that restore redox balance while modulating the senescent cell secretome

The goal is sustainable behaviour change that persists regardless of medication status

Explore its role in cellular health, antioxidant defense, and skincare for radiant, detoxified skin

(238) used bioinformatics methods to discover that the expression of nuclear receptor coactivator 4 (NCOA4) is reduced in ccRCC and is associated with a poor prognosis in ccRCC patients

1 and 2), led us to reason that cells treated with 5FU become more dependent upon mitochondrial function for survival